PGAP3 and neoplasm: As expected, co‐overexpression of PGAP3 and ERBB2 was also correlated with T stage (*p = 0.01), TNM stage (*p = 0.032), tumour size (*p = 0.032) and Lauren classification (**p = 0.008) (Table 3).